Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster lunch

807 - Prevalence and genotyping of HPV Infection in Jiangsu, a High-Risk Region of Esophageal Cancer from China (3P)


18 Nov 2017


Poster lunch


Cancer Prevention;  Oesophageal Cancer


Yan Miao


Annals of Oncology (2017) 28 (suppl_10): x1-x6. 10.1093/annonc/mdx652


Y. Miao, R. Liu, Y. Pu, L. Yin

Author affiliations

  • School Of Public Health, Southeast University, 210009 - Nanjing/CN


Abstract 807


An increasing number of studies have found HPV infection in esophageal carcinoma patients recently. However, reported rates of HPV infection as evidenced were divergent by differences in geographic regions of sample origin.


To detect the HPV status in Huai’an, China, a high-risk area for esophageal cancer (EC), ELISA was used to determine the seropositivity of HPV16/18 in the blood plasma of the high-risk population of Huai’an esophageal cancer. In the high-risk group, 937 volunteers were recruited by cluster sampling from high incident counties for esophageal cancer in Jiangsu during 2009 to 2013. For the patient group, HPV L1 DNA and HPV genotypes were identified in the cancerous tissues of 105 EC patients from the First People's Hospital in Huai’an by nested-PCR and dot blot hybridization.


The results showed that the overall rate of HPV infection in the high-risk group and the patient group was 31.4% and 34.36%, respectively. HPV18/16 covered 77.3% of HPV infection among the high-risk group. In the EC patient group, only HPV18 was detected in cancerous tissues, and the prevalence of infection (24.2%) was integrally higher than most related reports in other areas.


In conclusion, the current study evaluates the prevalence and genotyping of HPV infection in a high-risk population and patients with esophageal cancer in Huai’an, Jiangsu, and HPV18 may be the highest risk subtype of HPV infection in the Jiangsu area.

Clinical trial identification

Legal entity responsible for the study

School of Public Health, Southeast University


The National Science Foundation of China


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.